Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vyas

Showing results (301-310 of 357) with videos related to

Pageof 36
Sort By:
Die Pharmazie|October 20, 2007
Targeted intracellular delivery of therapeutics: an overviewA Rawat, B Vaidya, K Khatri, et al.
JCI Insight|January 23, 2026
The RNA binding protein Arid5a is an activator of TNF signaling in rheumatoid arthritisYang Li, Ipsita Dey, Shachi P Vyas, et al.
Cancer Research|August 1, 1982
Mutagenicity of the optical isomers of the diastereomeric bay-region chrysene 1,3-diol-3,4-epoxides in bacterial and mammalian cellsA W Wood, R L Chang, W Levin, et al.
Vaccine|May 18, 2011
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasallySharad Mangal, Dilip Pawar, Neeraj K Garg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and humanR A Halpin, E H Ulm, A E Till, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Efficient tumor targeting by polysaccharide decked polyethylenimine based nanocompositesAtul Pathak, Archana Swami, Soma Patnaik, et al.
Cancer Research|January 1, 1983
Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn miceR L Chang, W Levin, A W Wood, et al.
Current Medicinal Chemistry|August 19, 2007
Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA deliveryShivani Rai, Rishi Paliwal, Bhuvaneshwar Vaidya, et al.
Oncogene|May 13, 1999
Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1J D Shaughnessy, D A Largaespada, E Tian, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1993
In vivo and in vitro metabolism studies on a class III antiarrhythmic agentS Vickers, C A Duncan, P H Kari, et al.
Pageof 36

Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
Die Pharmazie|October 20, 2007
Targeted intracellular delivery of therapeutics: an overviewA Rawat, B Vaidya, K Khatri, et al.
JCI Insight|January 23, 2026
The RNA binding protein Arid5a is an activator of TNF signaling in rheumatoid arthritisYang Li, Ipsita Dey, Shachi P Vyas, et al.
Cancer Research|August 1, 1982
Mutagenicity of the optical isomers of the diastereomeric bay-region chrysene 1,3-diol-3,4-epoxides in bacterial and mammalian cellsA W Wood, R L Chang, W Levin, et al.
Vaccine|May 18, 2011
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasallySharad Mangal, Dilip Pawar, Neeraj K Garg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and humanR A Halpin, E H Ulm, A E Till, et al.
Journal of Biomedical Nanotechnology|January 9, 2010
Efficient tumor targeting by polysaccharide decked polyethylenimine based nanocompositesAtul Pathak, Archana Swami, Soma Patnaik, et al.
Cancer Research|January 1, 1983
Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn miceR L Chang, W Levin, A W Wood, et al.
Current Medicinal Chemistry|August 19, 2007
Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA deliveryShivani Rai, Rishi Paliwal, Bhuvaneshwar Vaidya, et al.
Oncogene|May 13, 1999
Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1J D Shaughnessy, D A Largaespada, E Tian, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1993
In vivo and in vitro metabolism studies on a class III antiarrhythmic agentS Vickers, C A Duncan, P H Kari, et al.
Pageof 36